Evaluation of Brain Dopaminergic Function using 18F-FDOPA PET in Parkinson's Disease and Related Disorders

Evaluation of Brain Dopaminergic Function using 18F-FDOPA PET in Parkinson's Disease and Related Disorders - 18F-FDOPA PET in Parkinson's Disease and Related Disorders

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000007779

Enrollment

Registered

2012-06-01

Start date

2012-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with Parkinson's disease based on the UK Brain Bank criteria 2. Patients with Parkinson's disease related disorders which are difficult to differentiate them from Parkinson's disease 3. Patients whose dopaminergic therapy can be stopped before PET if they have already started dopamine replacement therapy

Exclusion criteria

Exclusion criteria: 1. Patients who cannot stay rest on a scanner bed at least for 60 minutes

Design outcomes

Primary

Measure	Time frame
18F-FDOPA PET imaging	—

Countries

Japan

Contacts

Public ContactNaoya Oishi

Kyoto University Graduate School of Medicine Human Brain Research Center

noishi@kuhp.kyoto-u.ac.jp075-751-3695

Outcome results